WEF Names Personalized mRNA Cancer Vaccines and Exosome Drug Delivery Among Top 10 Emerging Technologies of 2026
Key Insights
The World Economic Forum (search)'s Top 10 Emerging Technologies of 2026 report highlights personalized mRNA cancer vaccines (search) that train a patient's immune system to target tumors using their genetic profile.
Exosome drug delivery (search) systems, which use the body's natural cellular packages to transport therapies precisely to diseased cells, also made the list.
Quantum simulation for drug discovery was recognized for its potential to identify promising drug candidates while cutting research time and cost.
The World Economic Forum (search) (WEF), in collaboration with scientific publisher Frontiers (search), has released its Top 10 Emerging Technologies of 2026 report, identifying innovations that have moved beyond laboratory research and are approaching real-world deployment. Among the ten technologies spotlighted, three are directly tied to pharmaceutical research and healthcare: personalized mRNA cancer vaccines (search), exosome drug delivery (search) systems, and quantum simulation for drug discovery.
The annual report marks what WEF describes as a decisive shift from software-first artificial intelligence toward technologies that act directly on physical systems—including power grids, drug pipelines, and biological processes.
Personalized mRNA Cancer Vaccines (search)
One of the most closely watched healthcare technologies on the list is personalized mRNA cancer vaccines (search), which are tailored to individual patients using the genetic profile of their tumors. According to the report, these vaccines work by training a patient's immune system to find and destroy cancer (search) cells, representing a fundamentally personalized approach to oncology.
The technology builds on the mRNA platform that gained widespread recognition during the COVID-19 pandemic, now redirected toward one of medicine's most persistent challenges. Rather than a standardized treatment, each vaccine is designed around the unique mutational landscape of a single patient's malignancy.
Exosome Drug Delivery (search)
Exosome drug delivery (search) systems also earned a place on the 2026 list. These systems harness naturally occurring biological particles—exosomes, the body's own cellular packages—to transport therapies precisely to diseased cells. The approach promises to improve the targeting of therapeutic agents while potentially reducing off-target effects that plague many current treatments.
The WEF report frames exosome-based delivery as part of a broader trend toward technologies that are "becoming more personal, designed around one patient or one context rather than a standardized whole."
Quantum Simulation for Drug Discovery
Quantum simulation for drug discovery was recognized for its potential to transform pharmaceutical research by identifying the most promising drug candidates through computational simulation of molecular behavior. The report notes that this approach could significantly cut the time and cost associated with traditional drug discovery pipelines, reflecting growing expectations that quantum computing could accelerate pharmaceutical research.
Precision Fermentation
Also relevant to the biopharmaceutical sector, precision fermentation—which uses genetically programmed microbes, electricity, and sugar in fermentation tanks to produce proteins, food ingredients, and medicines—was highlighted as a technology with potential to reshape manufacturing supply chains.
A Data-Driven Selection Process
This year's report was produced using an AI-based nomination workflow developed by Frontiers (search). The workflow systematically screened more than 1,200 candidate technologies across academic publications and industry sources, with cross-model validation. The list was then refined through expert assessment of each technology's novelty and real-world impact potential before final Advisory Council review.
Stephan Mergenthaler, Managing Director of the World Economic Forum (search), noted: "While each of these technologies has the potential to make a meaningful impact on its own, together they tell a broader story about where innovation is heading. They reveal new patterns across energy, medicine, and manufacturing that could challenge long-held assumptions about how we use technology to address some of the world's most pressing challenges such as food insecurity, climate change, and untreatable diseases."
Frederick Fenter, Chief Executive Editor of Frontiers (search), added: "This year's report marks a decisive shift—the technologies with the greatest impact are shifting from software towards the physical realm—even as artificial intelligence continues to support progress on many fronts."
The report offers a glimpse into where capital, research, and regulation may increasingly converge over the coming decade, with healthcare and biotechnology gaining momentum alongside energy transition technologies that dominated the list.